Full-Time

Software Engineer III

Tissue

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Compensation Overview

$99.3k - $124.1k/yr

Senior

Company Historically Provides H1B Sponsorship

Remote in USA

Category
Backend Engineering
Full-Stack Engineering
Software Engineering
Required Skills
Agile
React.js
MySQL
NoSQL
Node.js
Apache Kafka
Postgres
GraphQL
TypeScript
AWS
Requirements
  • 5+ years of overall software development experience, focusing on secure, scalable backend services using Node.js and TypeScript.
  • Hands-on experience with event-driven architecture and message processing (e.g., Apache Kafka).
  • Familiarity with React or other modern front-end frameworks for full-stack collaboration.
  • Solid understanding of the software development lifecycle (SDLC), including build, configuration, release, and deployment.
  • Experience or familiarity with Test-Driven Development (TDD) and/or Domain-Driven Design (DDD).
  • Knowledge of microservice architecture and distributed systems best practices.
  • Proficiency with AWS services (EC2, ECS, Lambda, Step Functions, SQS, SNS, S3).
  • Experience with GraphQL API design and implementation (e.g., Apollo Server).
  • Strong relational database skills (MySQL, PostgreSQL) and exposure to NoSQL databases.
  • Demonstrated teamwork skills and a collaborative mindset.
  • Excellent communication and organizational skills.
Responsibilities
  • Take ownership of assigned features and components, guiding them through the full software development lifecycle.
  • Contribute to design discussions, code reviews, and best practice adoption within the team.
  • Plan and prioritize tasks in an Agile environment, ensuring timely and high-quality delivery.
  • Work with Product Managers and stakeholders to refine requirements and scope technical efforts.
  • Mentor junior team members, sharing knowledge and best practices in Node.js, TypeScript, and microservice architectures.
  • Encourage a culture of continuous learning and technical excellence through pair programming and design reviews.
  • Partner with Product Managers, QA, and other cross-functional teams to gather requirements, validate designs, and guide projects from inception to deployment.
  • Coordinate with other engineering teams to integrate multiple systems and services that manage tissue samples and related data.
  • Drive improvements in our event-driven architecture and microservices approach, leveraging tools such as Apache Kafka, AWS EventBridge, or AWS Step Functions.
  • Advocate for high-quality standards and automated testing strategies to maintain a robust, scalable infrastructure.
Desired Qualifications
  • Experience with Bedrock and GenAI is a plus.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing kits and services, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for non-invasive cancer monitoring boosts Natera's Signatera test adoption.
  • Telehealth expansion supports Natera's remote genetic counseling services.
  • Rising organ transplant procedures increase demand for Natera's Prospera test.

What critics are saying

  • Increased competition from companies like Lantheus may impact Natera's market share.
  • Natera's CFO selling stock could indicate potential internal concerns.
  • Reliance on insurance reimbursements poses a risk if healthcare policies change.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for prenatal, oncology, and transplant health.
  • The company offers the unique Signatera test for personalized cancer monitoring.
  • Natera's Prospera Heart test uses a novel Donor Quantity Score for transplant rejection detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

9%
Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.

Financial Modeling Prep
Feb 28th, 2025
Lantheus Holdings, Inc. (NASDAQ:LNTH) Demonstrates Strong Capital Efficiency

Lantheus competes with other companies in the medical and pharmaceutical industries, such as ShockWave Medical, Medpace Holdings, LivaNova, Apellis Pharmaceuticals, and Natera.

BioSpace
Feb 19th, 2025
Natera To Report Its Fourth Quarter And Full Year Results On February 27, 2025

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2024, after the market closes on Feb. 27, 2025. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m

MarketBeat
Nov 24th, 2024
Alpha DNA Investment Management LLC Invests $505,000 in Natera, Inc. (NASDAQ:NTRA)

Alpha DNA Investment Management LLC invests $505,000 in Natera, Inc. (NASDAQ:NTRA).